Pinometostat is a first-in-class inhibitor of the DOT1L (disrupter of telomeric silencing 1-like) histone methyltransferase, an enzyme involved in the survival and proliferation of mixed lineage leukemia (MLL)-rearranged leukemia cells. The gene discussed is KMT2A; the disease is leukemia.